S. 579 · 117th Congress · Senate

A bill to make a technical correction to the ALS Disability Insurance Access Act of 2019.

Enacted· Became Public Law No: 117-3.
Introduced
Mar 3, 21
Passed Senate
Mar 3, 21
Passed House
Mar 11, 21
Sent to President
Mar 22, 21
Signed into Law
Mar 23, 21

Executive Summary

This bill retroactively eliminates the waiting period for Social Security Disability Insurance (SSDI) benefits for certain individuals with amyotrophic lateral sclerosis (ALS). Commonly known as Lou Gehrig's Disease, ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

Under current law, most SSDI recipients must wait five months after becoming disabled before their benefit payments may begin. The ALS Disability Insurance Access Act of 2019 eliminated the waiting period for individuals with ALS but only covers individuals who apply for benefits after the date of enactment (December 20, 2020). As a result, individuals with ALS who applied for SSDI benefits in the five months before that date are still subject to the waiting period. This bill eliminates the waiting period for those individuals.

Previous Versions

53Mar 11, 2021

This bill retroactively eliminates the waiting period for Social Security Disability Insurance (SSDI) benefits for certain individuals with amyotrophic lateral sclerosis (ALS). Commonly known as Lou Gehrig's Disease, ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

Under current law, most SSDI recipients must wait five months after becoming disabled before their benefit payments may begin. The ALS Disability Insurance Access Act of 2019 eliminated the waiting period for individuals with ALS but only covers individuals who apply for benefits after the date of enactment (December 20, 2020). As a result, individuals with ALS who applied for SSDI benefits in the five months before that date are still subject to the waiting period. This bill eliminates the waiting period for those individuals.

00Mar 3, 2021

This bill retroactively eliminates the waiting period for Social Security Disability Insurance (SSDI) benefits for certain individuals with amyotrophic lateral sclerosis (ALS). Commonly known as Lou Gehrig's Disease, ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

Under current law, most SSDI recipients must wait five months after becoming disabled before their benefit payments may begin. The ALS Disability Insurance Access Act of 2019 eliminated the waiting period for individuals with ALS but only covers individuals who apply for benefits after the date of enactment (December 20, 2020). As a result, individuals with ALS who applied for SSDI benefits in the five months before that date are still subject to the waiting period. This bill eliminates the waiting period for those individuals.

55Mar 3, 2021

This bill retroactively eliminates the waiting period for Social Security Disability Insurance (SSDI) benefits for certain individuals with amyotrophic lateral sclerosis (ALS). Commonly known as Lou Gehrig's Disease, ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord.

Under current law, most SSDI recipients must wait five months after becoming disabled before their benefit payments may begin. The ALS Disability Insurance Access Act of 2019 eliminated the waiting period for individuals with ALS but only covers individuals who apply for benefits after the date of enactment (December 20, 2020). As a result, individuals with ALS who applied for SSDI benefits in the five months before that date are still subject to the waiting period. This bill eliminates the waiting period for those individuals.

Action Timeline

17
  1. MAR 23, 2021BecameLaw

    Signed by President.

  2. MAR 23, 2021President

    Signed by President.

  3. MAR 23, 2021BecameLaw

    Became Public Law No: 117-3.

    117Yea
    3Nay
    0NV
  4. MAR 23, 2021President

    Became Public Law No: 117-3.

    117Yea
    3Nay
    0NV
  5. MAR 22, 2021President

    Presented to President.

  6. MAR 22, 2021Floor

    Presented to President.

  7. MAR 11, 2021Floor

    Mr

    Thompson (CA) asked unanimous consent to take from the Speaker's table and consider.

  8. MAR 11, 2021Floor

    Considered by unanimous consent

    (consideration: CR H1334)

  9. MAR 11, 2021Floor

    Passed/agreed to in House

    On passage Passed without objection.(text: CR H1334)

  10. MAR 11, 2021Floor

    On passage Passed without objection. (text: CR H1334)

  11. MAR 11, 2021Floor

    Motion to reconsider laid on the table

    Agreed to without objection.

  12. MAR 08, 2021Floor

    Message on Senate action sent to the House.

  13. MAR 08, 2021Floor

    Received in the House.

  14. MAR 08, 2021Floor

    Held at the desk.

  15. MAR 03, 2021IntroReferral

    Introduced in Senate

  16. MAR 03, 2021Floor

    Passed/agreed to in Senate

    Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent.(consideration: CR S1022; text: CR S1029)

  17. MAR 03, 2021Floor

    Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent. (consideration: CR S1022; text: CR S1029)